Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

The use of biological drugs has improved outcomes in pediatric inflammatory bowel disease (IBD). Prediction of the response to biological drugs would be extremely useful in IBD, and even more so in children, who are still growing physically and psychologically. Specific clinical, biochemical, and ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador-Martín, Sara, Melgarejo-Ortuño, Alejandra, López-Fernández, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617733/
https://www.ncbi.nlm.nih.gov/pubmed/34834201
http://dx.doi.org/10.3390/pharmaceutics13111786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617733/
https://www.ncbi.nlm.nih.gov/pubmed/34834201
http://dx.doi.org/10.3390/pharmaceutics13111786

Ejemplares similares